Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Department of Biotechnology allocates 10 pc of its annual budget for bio-tech activities in North-East

      Department of Biotechnology allocates 10 pc of its annual budget for bio-tech activities in North-East

      Ruby Khatun Khatun29 May 2017 11:56 AM IST
      New Delhi: With a view to promote biotechnology in North-Eastern Region (NER) of the country, the Department of Biotechnology (DBT) has allocated 10...
      Novartis receives FDA approval for expanded use of Zykadia in certain non-small cell lung cancer

      Novartis receives FDA approval for expanded use of Zykadia in certain non-small cell lung cancer

      Ruby Khatun Khatun29 May 2017 11:52 AM IST
      Basel: Novartis announced the US Food and Drug Administration (FDA) approved the expanded use of Zykadia® (ceritinib) to include the first-line...
      Zydus Wellness Q4 net up 9 pc at Rs 30 cr

      Zydus Wellness Q4 net up 9 pc at Rs 30 cr

      Ruby Khatun Khatun29 May 2017 11:51 AM IST
      New Delhi: Zydus Wellness reported a 9.3 per cent increase in consolidated net profit at Rs 30.32 crore for the quarter ended March 31.The company had...
      Generics-only drugs plan worries health experts: Indian pharma sector

      Generics-only drugs plan worries health experts: Indian pharma sector

      Ruby Khatun Khatun28 May 2017 10:30 AM IST
      Mumbai: India's plan to bring in a law to ensure doctors prescribe medicines only by their generic names risks proliferating the sale of substandard...
      Glenmark Pharma gets USFDA approval to sell generic blood pressure medicine

      Glenmark Pharma gets USFDA approval to sell generic blood pressure medicine

      Ruby Khatun Khatun28 May 2017 10:27 AM IST
      Glenmark Pharmaceuticals said it has received final approval from the US health regulator for its generic version Olmesartan Medoxomil Tablets, used...
      GW Pharmaceuticals to file cannabis drug as journal confirms epilepsy success

      GW Pharmaceuticals to file cannabis drug as journal confirms epilepsy success

      Ruby Khatun Khatun28 May 2017 10:23 AM IST
      GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in...
      Aster DM Healthcare launches Aster Emergency app for real time interface

      Aster DM Healthcare launches 'Aster Emergency' app for real time interface

      Ruby Khatun Khatun28 May 2017 9:31 AM IST
      A new mobile app which claims to provide help even before the ambulance arrives to give the 'basic life support' to a patient was launched on...
      Fortis Healthcare board approves increase in FII limit up to 74%

      Fortis Healthcare board approves increase in FII limit up to 74%

      Ruby Khatun Khatun28 May 2017 9:27 AM IST
      Fortis Healthcare on Friday announced that it has received its board’s approval to enhance the ceiling limit on total holdings of FII/FPI.It also...
      Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore

      Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore

      Ruby Khatun Khatun28 May 2017 9:27 AM IST
      Drug firm Indoco Remedies reported a 14.36 per cent decline in standalone net profit at Rs 17.94 crore for the March quarter.The company had posted a...
      Johnson n Johnson Slapped Rs 213 crore over lawsuit of Benadryl and other OTC drugs

      Johnson n Johnson Slapped Rs 213 crore over lawsuit of Benadryl and other OTC drugs

      Ruby Khatun Khatun27 May 2017 11:41 AM IST
      US: Johnson & Johnson has agreed to pay $33 million which is almost Rs. 213 crore to resolve charges by most U.S. states that it misrepresented...
      CCI order against Roche is anti-competition: HC

      CCI order against Roche is anti-competition: HC

      Ruby Khatun Khatun27 May 2017 11:38 AM IST
      New Delhi: The Delhi High Court termed as "anti-competition and anti-legal right", a Competition Commission of India's (CCI) order initiating an...
      Havas Group acquires healthcare agency Sorento

      Havas Group acquires healthcare agency Sorento

      Ruby Khatun Khatun27 May 2017 11:32 AM IST
      New Delhi: Global communications agency Havas Group has acquired Indian healthcare advertising agency Sorento for an undisclosed sum.Sorento will...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok